Alpha Cognition Return on Investment 2020-2024 | ACOG
Current and historical return on investment (ROI) values for Alpha Cognition (ACOG) over the last 10 years.
Alpha Cognition ROI - Return on Investment Historical Data |
Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
2024-06-30 |
$-0.01B |
$0.00B |
inf% |
2024-03-31 |
$-0.01B |
|
-4800.00% |
2023-12-31 |
$-0.01B |
|
-1333.33% |
2023-09-30 |
$-0.01B |
|
-1466.67% |
2023-06-30 |
$-0.01B |
$0.00B |
-1466.67% |
2023-03-31 |
$-0.01B |
$0.00B |
-2400.00% |
2022-12-31 |
$-0.01B |
|
inf% |
2022-09-30 |
$-0.01B |
|
inf% |
2022-06-30 |
$-0.01B |
|
-2800.00% |
2022-03-31 |
$-0.01B |
|
-2400.00% |
2021-12-31 |
$-0.01B |
|
-2200.00% |
2021-09-30 |
$-0.01B |
$0.00B |
-720.00% |
2021-06-30 |
$-0.01B |
$0.00B |
-1066.67% |
2021-03-31 |
$-0.01B |
$0.00B |
-1066.67% |
2020-12-31 |
$-0.01B |
$0.00B |
-933.33% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|